ORIC - Oric Pharmaceuticals, Inc. -  [ ]

Seasonality of Returns By Period

Average daily return by calendar bucket (ClosePriceSA).

Day of Week

Week of Month

Month of Year

Seasonal Path

YTD vs Last Year vs Lookback Avg · closes rebased to 100 at each year's first session
Ticker Details
Oric Pharmaceuticals, Inc.
IPO Date: April 24, 2020
Sector: Healthcare
Industry: Biotech
Market Cap: $1.24B
Activated in VL: True
Average Daily Range
Avg Daily Range: $0.47 | 3.83%
Avg Daily Range (30 D): $0.34 | 2.59%
Avg Daily Range (90 D): $0.37 | 3.26%
Institutional Daily Volume
Avg Daily Volume: .55M
Avg Daily Volume (30 D): 1.08M
Avg Daily Volume (90 D): 1.34M
Trade Size
Avg Trade Size (Sh.): 84
Avg Trade Size (Sh.) (30 D): 74
Avg Trade Size (Sh.) (90 D): 73
Institutional Trades
Total Institutional Trades: 1,360
Avg Institutional Trade: $1.72M
Avg Institutional Trade (30 D): $2.31M
Avg Institutional Trade (90 D): $2.05M
Avg Institutional Trade Volume: .15M
Avg Institutional Trades (Per Day): 1
Market Closing Trades
Avg Closing Trade: $2.01M
Avg Closing Trade (30 D): $3.36M
Avg Closing Trade (90 D): $2.92M
Avg Closing Volume: 176.78K
 
News
Aug 7, 2026 @ 8:30 PM
ORIC Pharmaceuticals Reports Inducement Grants und...
Source: Na
May 12, 2026 @ 9:41 PM
INVESTOR ALERT: Pomerantz Law Firm Investigates Cl...
Source: Pomerantz Llp
Apr 3, 2026 @ 8:30 PM
ORIC Pharmaceuticals Reports Inducement Grants und...
Source: Oric Pharmaceuticals, Inc.
Apr 1, 2026 @ 6:48 AM
ORIC Pharmaceuticals Stock Nosedives 25% After Hou...
Source: Tanya Rawat
Jan 14, 2026 @ 3:52 PM
Precision Killers: Why Big Pharma is Betting Billi...
Source: Prnewswire
Financials
  TTM Q2 2026 Q1 2026
Basic EPS $-1.32 $-.38 $-.34
Diluted EPS $-1.32 $-.38 $-.34
Revenue $M $M $M
Gross Profit
Net Income / Loss $-140.35M $-41.49M $-35.77M
Operating Income / Loss $-156.14M $-45.3M $-39.62M
Cost of Revenue
Net Cash Flow $-38.38M $-18.91M $10.73M
PE Ratio